Northern Trust’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-52,261
| Closed | -$454K | – | 4370 |
|
|
2018
Q2 | $454K | Buy |
52,261
+4,700
| +10% | +$42.3K | ﹤0.01% | 3620 |
|
|
2018
Q1 | $483K | Buy |
47,561
+17,009
| +56% | +$143K | ﹤0.01% | 3578 |
|
|
2017
Q4 | $148K | Buy |
30,552
+2,298
| +8% | +$11.2K | ﹤0.01% | 3897 |
|
|
2017
Q3 | $128K | Sell |
28,254
-100
| -0.4% | -$470 | ﹤0.01% | 3895 |
|
|
2017
Q2 | $143K | Hold |
28,354
| – | – | ﹤0.01% | 3891 |
|
|
2017
Q1 | $135K | Sell |
28,354
-5,588
| -16% | -$28.2K | ﹤0.01% | 3892 |
|
|
2016
Q4 | $190K | Sell |
33,942
-4,836
| -12% | -$26.5K | ﹤0.01% | 3774 |
|
|
2016
Q3 | $215K | Sell |
38,778
-4,286
| -10% | -$28.3K | ﹤0.01% | 3718 |
|
|
2016
Q2 | $302K | Sell |
43,064
-3,391
| -7% | -$23.9K | ﹤0.01% | 3619 |
|
|
2016
Q1 | $307K | Buy |
46,455
+3,605
| +8% | +$26.5K | ﹤0.01% | 3595 |
|
|
2015
Q4 | $442K | Buy |
42,850
+11,300
| +36% | +$131K | ﹤0.01% | 3546 |
|
|
2015
Q3 | $372K | Buy |
31,550
+13,298
| +73% | +$147K | ﹤0.01% | 3563 |
|
|
2015
Q2 | $167K | Sell |
18,252
-2,387
| -12% | -$18K | ﹤0.01% | 3820 |
|
|
2015
Q1 | $128K | Sell |
20,639
-1,496
| -7% | -$9.25K | ﹤0.01% | 3985 |
|
|
2014
Q4 | $124K | Hold |
22,135
| – | – | ﹤0.01% | 3938 |
|
|
2014
Q3 | $130K | Sell |
22,135
-45
| -0.2% | -$274 | ﹤0.01% | 3967 |
|
|
2014
Q2 | $152K | Sell |
22,180
-74
| -0.3% | -$495 | ﹤0.01% | 3918 |
|
|
2014
Q1 | $161K | Hold |
22,254
| – | – | ﹤0.01% | 3842 |
|
|
2013
Q4 | $147K | Buy |
22,254
+3,378
| +18% | +$23K | ﹤0.01% | 3793 |
|
|
2013
Q3 | $137K | Buy |
+18,876
| New | +$127K | ﹤0.01% | 3746 |
|
Northern Trust's JNP Position: Q3 2018 in Review
Northern Trust sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 52,261 shares — an estimated $454K sold.
Northern Trust first reported a position in JNP in Q3 2013 and held it in 20 quarters. The position peaked at $483K in Q1 2018. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.
- Northern Trust reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
- Northern Trust sold 52,261 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $454K.
- Northern Trust first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2013 and held it in 20 quarters.
- Northern Trust's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $483K in Q1 2018.
- 0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.
Based on Northern Trust's 13F filing for Q3 2018, filed 14 Nov 2018.